WallStSmart

MetLife Inc (MET) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

MetLife Inc stock (MET) is currently trading at $70.39. MetLife Inc PE ratio is 14.84. MetLife Inc PS ratio (Price-to-Sales) is 0.60. Analyst consensus price target for MET is $90.73. WallStSmart rates MET as Hold.

  • MET PE ratio analysis and historical PE chart
  • MET PS ratio (Price-to-Sales) history and trend
  • MET intrinsic value — DCF, Graham Number, EPV models
  • MET stock price prediction 2025 2026 2027 2028 2029 2030
  • MET fair value vs current price
  • MET insider transactions and insider buying
  • Is MET undervalued or overvalued?
  • MetLife Inc financial analysis — revenue, earnings, cash flow
  • MET Piotroski F-Score and Altman Z-Score
  • MET analyst price target and Smart Rating
MET

MetLife Inc

NYSEFINANCIAL SERVICES
$70.39
$0.50 (0.72%)
52W$63.33
$83.25
Target$90.73+28.9%

📊 No data available

Try selecting a different time range

IV

MET Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · MetLife Inc (MET)

Margin of Safety
-146.3%
Significantly Overvalued
MET Fair Value
$32.03
Graham Formula
Current Price
$70.39
$38.36 above fair value
Undervalued
Fair: $32.03
Overvalued
Price $70.39
Graham IV $32.03
Analyst $90.73

MET trades 146% above its Graham fair value of $32.03, indicating the stock may be overvalued at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

MetLife Inc (MET) · 10 metrics scored

Smart Score

63
out of 100
Grade: C+
Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in market cap, peg ratio, price/sales. Concerns around operating margin and eps growth. Fundamentals are solid but monitor weak areas for improvement.

MetLife Inc (MET) Key Strengths (6)

Avg Score: 9.2/10
PEG RatioValuation
0.6010/10

Growing significantly faster than its price suggests

Price/SalesValuation
0.6010/10

Paying less than $1 for every $1 of annual revenue

Institutional Own.Quality
77.23%10/10

77.23% of shares held by major funds and institutions

Market CapQuality
$46.05B9/10

Large-cap company with substantial market presence

Price/BookValuation
1.578/10

Trading at 1.57x book value, attractively priced

Revenue GrowthGrowth
27.60%8/10

Strong revenue growth at 27.60% annually

Supporting Valuation Data

P/E Ratio
14.84
Undervalued
Forward P/E
7.41
Attractive
Trailing P/E
14.84
Undervalued
Price/Sales (TTM)
0.597
Undervalued
EV/Revenue
0.793
Undervalued
MET Target Price
$90.73
21% Upside

MetLife Inc (MET) Areas to Watch (4)

Avg Score: 2.0/10
EPS GrowthGrowth
-34.20%0/10

Earnings declining -34.20%, profits shrinking

Operating MarginProfitability
4.67%1/10

Near-zero operating margins, business under pressure

Profit MarginProfitability
4.38%2/10

Very thin margins, barely profitable

Return on EquityProfitability
12.00%5/10

Moderate profitability with room for improvement

MetLife Inc (MET) Detailed Analysis Report

Overall Assessment

This company scores 63/100 in our Smart Analysis, earning a C+ grade. Out of 10 metrics analyzed, 6 register as strengths (avg 9.2/10) while 4 fall into concern territory (avg 2.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on PEG Ratio, Price/Sales, Institutional Own.. Valuation metrics including PEG Ratio (0.60), Price/Sales (0.60), Price/Book (1.57) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 27.60%.

The Bear Case

The primary concerns are EPS Growth, Operating Margin, Profit Margin. Growth concerns include EPS Growth at -34.20%, which may limit upside. Profitability pressure is visible in Return on Equity at 12.00%, Operating Margin at 4.67%, Profit Margin at 4.38%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 12.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 27.60% strong but requiring continuation.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (PEG Ratio, Price/Sales) and negatives (EPS Growth, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

MET Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

MET's Price-to-Sales ratio of 0.60x trades 19% below its historical average of 0.74x (21th percentile). The current valuation is 43% below its historical high of 1.05x set in Oct 2007, and 298% above its historical low of 0.15x in Aug 2016.

Compare MET with Competitors

Top INSURANCE - LIFE stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for MetLife Inc (MET) · FINANCIAL SERVICESINSURANCE - LIFE

The Big Picture

MetLife Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 77.1B with 28% growth year-over-year. Profit margins are strong at 438.0%, reflecting pricing power and operational efficiency.

Key Findings

Strong Revenue Growth

Revenue growing at 28% YoY, reaching 77.1B. This pace significantly outperforms most INSURANCE - LIFE peers.

Excellent Capital Efficiency

ROE of 1200.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.

What to Watch Next

Growth sustainability: can MetLife Inc maintain 28%+ revenue growth, or will competition slow it down?

Dividend sustainability with a current yield of 3.3%. Watch payout ratio and free cash flow coverage.

Sector dynamics: monitor INSURANCE - LIFE industry trends, competitive moves, and regulatory changes that could impact MetLife Inc.

Bottom Line

MetLife Inc offers an attractive blend of growth (28% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About MetLife Inc(MET)

Exchange

NYSE

Sector

FINANCIAL SERVICES

Industry

INSURANCE - LIFE

Country

USA

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with 90 million customers in over 60 countries.